These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8335524)

  • 1. The mouse peritonitis model: present and future use.
    Frimodt-Møller N
    J Antimicrob Chemother; 1993 May; 31 Suppl D():55-60. PubMed ID: 8335524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation.
    Eagye KJ; Kuti JL; Dowzicky M; Nicolau DP
    Clin Ther; 2007 May; 29(5):889-899. PubMed ID: 17697907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.
    Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 1998 Apr; 41(4):451-9. PubMed ID: 9598776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critique of animal models in antibiotic research.
    Barza M
    Scand J Infect Dis Suppl; 1978; (14):109-17. PubMed ID: 279963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary rodent infection models for testing antibacterial compound efficacy in vivo.
    Marra A; Girard D
    Curr Protoc Pharmacol; 2006 Jan; Chapter 13():Unit13A.4. PubMed ID: 21953399
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous bacterial peritonitis due to multidrug resistant bacteria: are the current guidelines outdated?
    Fiore M
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):731. PubMed ID: 27111388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary peritonitis in children. Apropos of 12 case reports].
    Janati R; Takvorian P; Dodat H; Chappuis JP
    Chir Pediatr; 1986; 27(4):201-4. PubMed ID: 3545516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.
    Li YT; Yu CB; Huang JR; Qin ZJ; Li LJ
    World J Gastroenterol; 2015 Sep; 21(36):10409-17. PubMed ID: 26420967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic therapy of intra-abdominal infections in the era of multiresistance].
    Eckmann C
    Chirurg; 2016 Jan; 87(1):26-33. PubMed ID: 26577434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.
    Li GQ; Bai XG; Li CR; Yang XY; Hu XX; Yuan M; Zhang WX; Lou RH; Guo HY; Jiang JD; You XF
    J Antimicrob Chemother; 2012 Apr; 67(4):955-61. PubMed ID: 22210757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 4% gelofusine plus antibiotics on renal impairment and mortality in high-risk cirrhotic patients with spontaneous bacterial peritonitis.
    Sirinthornpunya S; Luangvichcharoen K
    J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S77-83. PubMed ID: 23682527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of anaerobic infection in peritonitis of appendicular origin and effects of antibiotics].
    Hájková H; Tichý S; Závadová M
    Rozhl Chir; 1979 Oct; 58(10):651-8. PubMed ID: 542858
    [No Abstract]   [Full Text] [Related]  

  • 16. Peritonitis after cecal perforation. An experimental model to study the therapeutic role of antibiotics associated with allopurinol and catalase.
    Castillo M; Toledo-Pereyra LH; Gutierrez R; Prough D; Shapiro E
    Am Surg; 1991 May; 57(5):313-6. PubMed ID: 2039130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating empiric treatment options for secondary peritonitis using pharmacodynamic profiling.
    Eagye KJ; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2007 Apr; 8(2):215-26. PubMed ID: 17437367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
    Kajihara T; Nakamura S; Iwanaga N; Oshima K; Hirano K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Hattori N; Kohno N; Kohno S; Mukae H
    J Infect Chemother; 2017 Jul; 23(7):498-501. PubMed ID: 28108098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A contemporary situation in the antimicrobial treatment of the secondary peritonitis].
    Vyhnánek F; Vranková J
    Rozhl Chir; 2005 Sep; 84(9):466-71. PubMed ID: 16250620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.
    Friedrich K; Nüssle S; Rehlen T; Stremmel W; Mischnik A; Eisenbach C
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1191-5. PubMed ID: 26676553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.